A binary QSAR model for classification of hERG potassium channel blockers
- PMID: 18243713
- DOI: 10.1016/j.bmc.2008.01.017
A binary QSAR model for classification of hERG potassium channel blockers
Abstract
Acquired long QT syndrome causes severe cardiac side effects and represents a major problem in clinical studies of drug candidates. One of the reasons for development of arrhythmias related to long QT is inhibition of the human ether-a-go-go-related-gene (hERG) potassium channel. Therefore, early prediction of hERG K(+) channel affinity of drug candidates is becoming increasingly important in the drug discovery process. Binary QSAR models with threshold values at IC(50)=1 and of 10 microM, respectively, were generated using two different sets of descriptors. One set comprising 32 P_VSA descriptors and the other one utilizing a set of descriptors identified out of a large set via a feature selection algorithm. For the full dataset, the power for classification of hERG blockers was 82-88%, which meets prior classification models. Considering the fact that 2D descriptors are fast and easy to calculate, these binary QSAR models are versatile tools for use in virtual screening protocols.
Similar articles
-
Classification models for HERG inhibitors by counter-propagation neural networks.Chem Biol Drug Des. 2008 Oct;72(4):279-89. doi: 10.1111/j.1747-0285.2008.00705.x. Chem Biol Drug Des. 2008. PMID: 18844674
-
A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.Chem Res Toxicol. 2011 Jun 20;24(6):934-49. doi: 10.1021/tx200099j. Epub 2011 May 6. Chem Res Toxicol. 2011. PMID: 21504223
-
hERG classification model based on a combination of support vector machine method and GRIND descriptors.Mol Pharm. 2008 Jan-Feb;5(1):117-27. doi: 10.1021/mp700124e. Epub 2008 Jan 16. Mol Pharm. 2008. PMID: 18197627
-
[HERG K+ channel, the target of anti-arrhythmias drugs].Yao Xue Xue Bao. 2007 Jul;42(7):687-91. Yao Xue Xue Bao. 2007. PMID: 17882949 Review. Chinese.
-
Predictive models for HERG channel blockers: ligand-based and structure-based approaches.Curr Med Chem. 2007;14(28):3003-26. doi: 10.2174/092986707782794087. Curr Med Chem. 2007. PMID: 18220737 Review.
Cited by
-
Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.J Med Chem. 2012 Apr 12;55(7):3261-73. doi: 10.1021/jm201705f. Epub 2012 Mar 27. J Med Chem. 2012. PMID: 22452412 Free PMC article.
-
Computational determination of hERG-related cardiotoxicity of drug candidates.BMC Bioinformatics. 2019 May 29;20(Suppl 10):250. doi: 10.1186/s12859-019-2814-5. BMC Bioinformatics. 2019. PMID: 31138104 Free PMC article.
-
Tuning HERG out: antitarget QSAR models for drug development.Curr Top Med Chem. 2014;14(11):1399-415. doi: 10.2174/1568026614666140506124442. Curr Top Med Chem. 2014. PMID: 24805060 Free PMC article.
-
A support vector machine classification model for benzo[c]phenathridine analogues with toposiomerase-I inhibitory activity.Molecules. 2012 Apr 17;17(4):4560-82. doi: 10.3390/molecules17044560. Molecules. 2012. PMID: 22510606 Free PMC article.
-
Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.Acta Pharmacol Sin. 2014 Aug;35(8):1093-102. doi: 10.1038/aps.2014.35. Epub 2014 Jun 30. Acta Pharmacol Sin. 2014. PMID: 24976154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information